EndoGlow, a medical device manufacturer that worked with the University of Rochester under a FuzeHub Manufacturing Grant, has been named to the Top 10 Minimally Invasive Device Solutions Providers list for 2020 by MedTech Outlook. EndoGlow is a Rochester, New York company that produces fluorescent medical devices to enhance visualization during minimally invasive surgeries. MedTech Outlook is a leading technology magazine for the medical device industry that highlights trending technologies.
In 2018, FuzeHub awarded the Department of Obstetrics and Gynecology at the University of Rochester a $50,000 Manufacturing Grant for a project with EndoGlow. The purpose of this project was to produce a medical device that fluoresces using near-infrared (NIR) imaging for clinical evaluation. Known as the GreenEgg™, the device is used in robotic-assisted surgery to help surgeons identify critical anatomy and improve surgical efficiency.
The 2018 Manufacturing Grant, which is part of the Jeff Lawrence Innovation Fund, supported a project for complete proof-of-concept manufacturing. This included injection molding, safety testing, sterilization, and packaging validation necessary for FDA approval. A mold for manufacturing GreenEgg™ devices was fabricated and data from clinical evaluation trials supported an application to the U.S. Food and Drug Administration.
Dr. Paula Jaye Doyle, EndoGlow’s Chief Medical Officer (CMO), recently told FuzeHub about the company’s inclusion in MedTech Outlook’s Top 10 list of minimally invasive medical device solutions. “What a great way to start the year,” said the EndoGlow CMO and University of Rochester physician. Dr. Doyle, whose medical practice specializes in reconstructive pelvic surgery in women, also predicted “many more exciting things to come in 2021.”
The GreenEgg™ from EndoGlow is a Class 1 medical device that is used in gynecologic, urologic, and colorectal surgeries. The GreenEgg™ incorporates Tissue Reveal Technology™ and, with NIR imaging enabled, enhances identification of anatomical structures and tissue layers. EndoGlow’s fluorescent devices provide an alternative to indocyanine green (ICG) dyes that are injected into patients and used in medical diagnostics. This simplifies surgical planning for busy doctors.
Visit EndoGlow’s website for more information about this transformative technology from an NYS manufacturer that benefitted from the Jeff Lawrence Innovation Fund, which supports activities designed to spur technology development and commercialization.
